Skip to main content

Table 4 Sensitivity analysis of association between sarcopenia and new-onset kidney diseases in CHARLS (2011–2015) excluding individuals with eGFR less than 90

From: Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study

 

Cases (n)

Incidence Rate, per 1000 Person-Years

HR (95%CI)

Model 1

Model 2

Model 3

Model 4

No sarcopenia

116

54.84

1.00 (Ref.)

1.00 (Ref.)

1.00 (Ref.)

1.00 (Ref.)

Possible sarcopenia

258

55.97

1.04 (0.84–1.29)

1.14 (0.91–1.43)

1.14 (0.90–1.43)

1.13 (0.90–1.42)

Sarcopenia

111

91.40

1.67 (1.28–2.17)***

1.60 (1.23–2.08)***

1.51 (1.15–1.97)**

1.64 (1.19–2.26)**

  1. • Abbreviation: HRs, hazard ratios; CI, confidential interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
  2. • Model 1 was unadjusted
  3. • Model 2 was adjusted for age, sex
  4. • Model 3 was adjusted for age, sex, drinking, height, weight, eGFR, HDL cholesterol
  5. • Model 4 was adjusted for age, sex, residence, marital status, educational level, smoking, drinking, BMI, SBP, DBP; history of hypertension, dyslipidemia, diabetes, stroke, heart disease
  6. • Significant at * P < 0.05** P < 0.01.*** P < 0.001